RecruitingPhase 2NCT06118567

Effect of Nitrous Oxide on Aggression.

Nitrous Oxide and Cortico-Limbic Function in Aggression


Sponsor

Ohio State University

Enrollment

50 participants

Start Date

Sep 6, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this experimental medicine clinical trial is to test the hypothesis that nitrous oxide inhalation will result in a change in neurocircuit function in healthy controls and in individuals with impulsive aggressive tendencies. The main question aims to answer are: Does Nitrous Oxide normalize brain circuit function in impulsively aggressive individuals 24 hours after inhalation. Participants will undergo a 60 minute inhalation session with 50% Nitrous Oxide (or room air at another session) and then undergo an fMRI scan 24 hours later. Researchers will compare healthy controls and impulsively aggressive individuals to see if Nitrous Oxide can normalize the function of cortico-limbic circuits in the latter group.


Eligibility

Min Age: 21 YearsMax Age: 55 Years

Inclusion Criteria11

  • All participants:
  • Between 21 and 55 years of age.
  • Physically healthy (no clinically significant medical condition as confirmed by medical history/physical exam).
  • Able to give informed consent.
  • Aggressive (IED) Study Participants (n = 25 Completed; 75 Enrolled).
  • Current DSM-5 Criteria for IED
  • LHA Aggression scores > 12
  • Negative for a history of psychosis, bipolar disorder, developmental disorder, intellectual disability or a current substance use disorder.
  • Healthy, Non-Aggressive, Controls (n = 25 Completed, 75 Enrolled).
  • Do not meet current/lifetime DSM-5 Criteria for any psychiatric disorder
  • LHA aggression scores < 12

Exclusion Criteria9

  • PCL Screening Version Score > 13; i.e., subject is likely to be psychopathic.32
  • Current DSM-5 Major Depressive Episode.
  • Life history of bipolar disorder/schizophrenia/organic mental syndrome.
  • Intellectual disability \[i.e., IQ < 70\].
  • History of N2O abuse/dependence.
  • Clinically significant medical condition.
  • Current alcohol/drug use disorder of moderate or severe severity (i.e., subject is not in full remission from moderate to severe alcohol/drug use).
  • Two weeks free of antipsychotic medication. (Note: Because a large number of individuals with aggressive tendencies in the community are already taking SSRIs, SNRIs, or mood stabilizers, these individuals will not be excluded if they continue to report impulsive aggressive behaviors at time of study.)
  • Unwilling/unable to sign informed consent document.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNitrous oxide

Nitrous oxide gas.

DRUGRoom Air

Room Air


Locations(1)

Ohio State University Wexner Medical Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06118567


Related Trials